The compound B-asarone has been identified as an inhibitor of HNRNPA2/B1 and was able to supress glioma by inhibiting invasion and inducing cell-cycle arrest and apoptosis [110]. The gene discussed is HNRNPA2B1; the disease is central nervous system cancer.